Clinical Trial Update: Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 2 Diabetes Mellitus When Failing on OADs [Phase 4]

View source ↗

Summary

A Phase 4 trial assessing the efficacy and safety of Biphasic Insulin Aspart 30 in type 2 diabetes patients not adequately controlled on oral antidiabetic drugs…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Biphasic insulin aspart 30 (insulin aspart, biphasic 30/70)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2010-08-17